Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
1.
Oman Medical Journal. 2017; 32 (1): 36-40
de Anglais | IMEMR | ID: emr-185723

RÉSUMÉ

Objectives: The aim of this study was to estimate the prevalence and identify the risk factors for the development of drug-resistant Mycobacterium tuberculosis infection in a tertiary care center in Oman


Methods: We performed a cross-sectional review of culture-confirmed tuberculosis [TB] cases diagnosed at Sultan Qaboos University Hospital between August 2006 and March 2015. We compared drug-resistant TB cases with drug-sensitive cases to identify predictors of drug-resistant TB using univariate and multivariate logistic regression analysis


Results: Of the 260 TB cases reviewed, 73.1% were confirmed by culture. The proportion of multi-drug resistant TB was 1.8%. TB isolates resistant to any of the first-line TB drugs comprised [7.5%] of cases. Pyrazinamide monoresistance was the most frequently reported drug monoresistant pattern [3.5%]. Previous treatment for TB [odds ratio [OR] 14.81; 95% CI 3.09-70.98, p < 0.001], female gender [OR 3.85; 95% Cl 1.07-13.90, p < 0.039], and younger age [OR 6.80; 95% Cl 1.61-28.75, p < 0.009] were found to be risk factors for development of first-line antituberculosis drug-resistant TB in multivariate analysis


Conclusions: Our results show that the rate of drug-resistant TB in our population is a public health issue of great concern. Previous treatment with antituberculosis drugs, female gender, and younger age are risk factors for the development of drug-resistant TB. These findings are useful adjuvants to guide clinicians and public health professionals in the early detection and appropriate treatment of cases of drug-resistant TB


Sujet(s)
Humains , Femelle , Nouveau-né , Nourrisson , Enfant d'âge préscolaire , Enfant , Adolescent , Jeune adulte , Adulte , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Centres de soins tertiaires , Études transversales , Facteurs de risque , Modèles logistiques
2.
Oman Medical Journal. 2015; 30 (1): 59-62
de Anglais | IMEMR | ID: emr-168166

RÉSUMÉ

Hughes-Stovin syndrome is a very rare clinical entity characterized by pulmonary artery aneurysms and deep vein thrombosis [DVT]. Here we report the case of a 53-year-old man, admitted to Sultan Qaboos University Hospital, Muscat, Oman, with bilateral pulmonary artery aneurysms and lower-limb DVT who developed massive hemoptysis. He was managed successfully with high-dose steroids in combination with cyclophosphamide


Sujet(s)
Humains , Mâle , Anévrysme , Thrombose veineuse , Syndrome , Hémoptysie/traitement médicamenteux , Prise en charge de la maladie , Tomodensitométrie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE